首页> 美国卫生研究院文献>other >Incidence of recurrent fungal keratitis after primary keratoplasty and visual outcome and prognosis after intervention for the recurrence
【2h】

Incidence of recurrent fungal keratitis after primary keratoplasty and visual outcome and prognosis after intervention for the recurrence

机译:原发性角膜移植术后复发性真菌性角膜炎的发生率和视觉结果以及干预后的预后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There are no standardized protocols or guidelines for the treatment of recurrent fungal keratitis after therapeutic keratoplasty. This study aimed to investigate the incidence of recurrent fungal keratitis after the primary keratoplasty and the visual outcome and prognosis after intervention for the recurrence.This was a retrospective study. Patients with recurrent fungal keratitis after lamellar keratoplasty (LK) or penetrating keratoplasty (PK) were treated with different antifungal regimens at Shandong Eye Hospital and Qingdao Eye Hospital between Januray 2004 and December 2015. The operative techniques included PK, focal excision, tectonic keratoplasty with a patch graft, lensectomy and vitrectomy, and combined operation. Patients were followed at 1, 2, and 3 months, and then every 6 months after surgery for 2 years. Best corrected visual acuity was assessed and recurrence was recorded. Good prognosis was defined as the presence of visual acuity.Fungal keratitis recurred in 112 of 1448 patients (112/1448, 7.7%) treated initially with PK or LK. The good prognosis rates for different sites of recurrent fungal keratitis were: overall, 93 of 112 (83.0%); recipient bed, 64 of 69 (92.8%); anterior chamber, 14 of 14 (100%); posterior segment, 10 of 16 (62.5%); and atypical, 5 of 13 (38.5%). There was no significant difference in the timing of recurrence between the good and poor prognosis groups (P = .518). Recurrence rates were similar between patients with PK (8.6%) and those with LK (6.0%; P > .05), but the good prognosis rate in patients with post-LK recurrence (96.8%) was higher than that in patients with post-PK recurrence (77.8%, P = .017).Individualized treatment according to recurrent sites of fungal keratitis can achieve a good prognosis in most patients.
机译:没有治疗性角膜移植术后复发性真菌性角膜炎的标准化治疗方案或指南。本研究旨在回顾性研究原发性角膜移植术后复发性真菌性角膜炎的发生率以及干预后的视觉结果和预后。 2004年1月至2015年12月间,在山东省眼科医院和青岛眼科医院对不同的抗真菌方案进行了片状角膜移植术(LK)或穿透性角膜移植术(PK)后复发的真菌性角膜炎的患者。手术技术包括PK,局灶性切除,组织学角膜移植和补片,晶状体切除术和玻璃体切除术,以及联合手术。在1、2和3个月时对患者进行随访,然后在手术后每6个月随访2年。评估最佳矫正视力并记录复发。视力的存在预后良好。最初用PK或LK治疗的1448例患者中有112例复发了真菌性角膜炎(112/1448,7.7%)。复发性真菌性角膜炎的不同部位的预后良好:总体上,在112个中有93个(83.0%);接受者床位,占69位中的64位(92.8%);前房,14中的14(100%);后段,16的10(62.5%);和非典型的,在13中的5中占38.5%。良好和不良预后组的复发时间无显着差异(P = .518)。 PK患者(8.6%)和LK患者(6.0%; P> .05)的复发率相似,但LK术后复发患者的良好预后率(96.8%)高于LK术后患者-PK复发(77.8%,P = .017)。根据真菌性角膜炎复发部位的个体化治疗在大多数患者中可以取得良好的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号